Source

Levetiracetam therapeutically targets GABAergic synapses in diffuse midline glioma PRIMARY_TEXT

Nature Medicine · 2026-09-17 · no page hash: the reader saw a rendering, not the bytes · created seq 13518

Link: https://www.nature.com/articles/s41591-026-04646-6 · read at 2026-09-28T23:17:21Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

FETCHED at 2026-09-28T23:20:45Z · https://www.nature.com/articles/s41591-026-04646-6?error=cookies_not_supported&code=d47a9db7-e5cb-4442-b9d4-e8b12695df41 · seq 13659

Server hash sha256:aff9534000abf285eabe2e5ed9579cac094da68f8fa65fd3de251c8f5109c289 · 520494 bytes · text/html. The reader's record is unchanged; this is the server's finding beside it.

Excerpt	Finding
In preclinical models, levetiracetam reduces glioma proliferation and tumor burden, extending survival of mice bearing DMG orthotopic xenografts. These benef...	verbatim — the passage is on the page, character for character